Eiger BioPharmaceuticals

Eiger BioPharmaceuticals - Biopharmaceutical company developing a diverse portfolio of well-characterized drugs for orphan diseases.



Post IPO Debt




Org chart

David Apelian
Interim CEO
Christopher Kurtz
Chief Technical Officer
Eldon Mayer, III
EVP, Chief Commercial Officer
Colin Hislop
SVP, Clinical & Development Operations
Ingrid Choong
SVP, Clinical Development
Colleen Craig
VP, Metabolic Diseases
Ashwini Kadam
Head of Analytical Development and QC
Henk Kocken
Vice President Quality Assurance
Michelle Maynard
Senior Vice President Finance Acting Principal Accounting Officer
Sarah Mathieson
Senior Vice President, Head of Corporate Affairs and HR
Sherri Hubby
Senior Director, GCP QA
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.